Clinical Trials Directory

Trials / Unknown

UnknownNCT04186026

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Effect of Combination of the Gut Hormones Neurotensin and GLP-1 on Physiological Regulation of Appetite and Food Intake

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Detailed description

Neurotensin (NT), a gut hormone and neuropeptide, and GLP-1, as well a gut hormone, increases in circulation after bariatric surgery in rodents and humans and inhibit food intake in mice. Studies in rodents have shown that a GLP-1 receptor agonist and long acting neurotensin inhibit food intake. This study investigates whether the synergistic anorexic effects of neurotensin and GLP-1 agonism suggested by animal studies can be translated.

Conditions

Interventions

TypeNameDescription
OTHERSaline + salineDouble saline infusion followed by an ad libitum meal
OTHERNeurotensin + salineNeurotensin + saline infusion followed by an ad libitum meal
OTHERGLP-1 + salineGLP-1 + saline infusion followed by an ad libitum meal
OTHERGLP-1 + NeurotensinGLP-1 + Neurotensin infusion followed by an ad libitum meal

Timeline

Start date
2019-10-01
Primary completion
2024-06-10
Completion
2024-06-30
First posted
2019-12-04
Last updated
2023-05-17

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04186026. Inclusion in this directory is not an endorsement.